Martin O’Rourke, PhD, is senior director, Oncology In-Vitro Biosciences, Integrated Drug Discovery at Charles River Laboratories.
The Power of In Vitro Assays in Immuno-Oncology
The combination of translatable in-vitro and in-vivo assays, coupled with expertise in immunology and oncology helps facilitate the progression of novel oncology therapeutics from hit identification to investigational new drug submission.